Humana Financial Statements (HUM)
|
|
|
|
Report date
|
|
|
17.02.2022 |
16.02.2023 |
15.02.2024 |
20.02.2025 |
19.02.2026 |
|
29.04.2026 |
|
Currency
|
|
|
USD |
USD |
USD |
USD |
USD |
|
USD |
|
Financial report URL
|
|
|
|
|
|
|
|
|
|
|
|
Revenue, bln rub |
? |
|
83 648 |
92 922 |
106 440 |
117 811 |
129 664 |
|
137 200 |
|
Operating Income, bln rub |
|
|
3 419 |
3 564 |
3 320 |
1 627 |
1 453 |
|
1 384 |
|
EBITDA, bln rub |
? |
|
4 458 |
4 810 |
4 730 |
3 255 |
2 908 |
|
2 851 |
|
Net profit, bln rub |
? |
|
2 933 |
2 806 |
2 489 |
1 207 |
1 188 |
|
1 130 |
|
|
OCF, bln rub |
? |
|
2 262 |
4 587 |
3 981 |
2 966 |
921.0 |
|
1 844 |
|
CAPEX, bln rub |
? |
|
1 342 |
1 137 |
1 004 |
575.0 |
546.0 |
|
572.0 |
|
FCF, bln rub |
? |
|
920.0 |
3 450 |
2 977 |
2 391 |
375.0 |
|
1 272 |
|
Dividend payout, bln rub
|
|
|
354.0 |
392.0 |
431.0 |
431.0 |
430.0 |
|
429.0 |
|
|
Ordinary share dividend yield, %
|
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0.00% |
|
Dividend payout ratio, %
|
|
|
12.1% |
14.0% |
17.3% |
35.7% |
36.2% |
|
38.0% |
|
|
OPEX, bln rub |
|
|
11 030 |
13 668 |
14 726 |
15 520 |
17 399 |
|
17 832 |
|
Cost of production, bln rub |
|
|
69 199 |
75 690 |
88 394 |
100 664 |
110 812 |
|
117 984 |
|
R&D, bln rub |
|
|
0.000 |
0.000 |
0.000 |
0.000 |
0.000 |
|
0.000 |
|
Interest expenses, bln rub |
|
|
326.0 |
401.0 |
493.0 |
660.0 |
631.0 |
|
664.0 |
|
|
Assets, bln rub |
|
|
44 748 |
43 725 |
46 892 |
46 312 |
48 750 |
|
55 280 |
|
Net Assets, bln rub |
? |
|
16 080 |
15 311 |
16 262 |
16 375 |
17 657 |
|
18 580 |
|
Debt, bln rub |
|
|
13 225 |
11 753 |
12 269 |
12 260 |
12 937 |
|
13 993 |
|
Cash, bln rub |
|
|
3 394 |
5 061 |
4 694 |
2 221 |
4 200 |
|
21 965 |
|
Net debt, bln rub |
|
|
9 831 |
6 692 |
7 575 |
10 039 |
8 737 |
|
-7 972 |
|
|
Ordinary share price, rub |
|
|
463.9 |
512.2 |
457.8 |
253.7 |
256.1 |
|
267.3 |
|
Number of ordinary shares, mln |
|
|
128.7 |
126.4 |
123.9 |
120.6 |
120.5 |
|
120.3 |
|
|
Market cap, bln rub |
|
|
59 693 |
64 751 |
56 707 |
30 590 |
30 852 |
|
32 170 |
|
EV, bln rub |
? |
|
69 524 |
71 443 |
64 282 |
40 629 |
39 589 |
|
24 198 |
|
Book value, bln rub |
|
|
2 349 |
4 404 |
5 019 |
5 301 |
6 843 |
|
8 091 |
|
|
EPS, rub |
? |
|
22.8 |
22.2 |
20.1 |
10.0 |
9.86 |
|
9.39 |
|
FCF/share, rub |
|
|
7.15 |
27.3 |
24.0 |
19.8 |
3.11 |
|
10.6 |
|
BV/share, rub |
|
|
18.3 |
34.8 |
40.5 |
44.0 |
56.8 |
|
67.2 |
|
|
EBITDA margin, % |
? |
|
5.33% |
5.18% |
4.44% |
2.76% |
2.24% |
|
2.08% |
|
Net margin, % |
? |
|
3.51% |
3.02% |
2.34% |
1.02% |
0.92% |
|
0.82% |
|
FCF yield, % |
? |
|
1.54% |
5.33% |
5.25% |
7.82% |
1.22% |
|
3.95% |
|
ROE, % |
? |
|
18.2% |
18.3% |
15.3% |
7.37% |
6.73% |
|
6.08% |
|
ROA, % |
? |
|
6.55% |
6.42% |
5.31% |
2.61% |
2.44% |
|
2.04% |
|
|
P/E |
? |
|
20.4 |
23.1 |
22.8 |
25.3 |
26.0 |
|
28.5 |
|
P/FCF |
|
|
64.9 |
18.8 |
19.0 |
12.8 |
82.3 |
|
25.3 |
|
P/S |
? |
|
0.71 |
0.70 |
0.53 |
0.26 |
0.24 |
|
0.23 |
|
P/BV |
? |
|
25.4 |
14.7 |
11.3 |
5.77 |
4.51 |
|
3.98 |
|
EV/EBITDA |
? |
|
15.6 |
14.9 |
13.6 |
12.5 |
13.6 |
|
8.49 |
|
Debt/EBITDA |
|
|
2.21 |
1.39 |
1.60 |
3.08 |
3.00 |
|
-2.80 |
|
|
R&D/CAPEX, % |
|
|
0.00% |
0.00% |
0.00% |
0.00% |
0.00% |
|
0 |
|
|
CAPEX/Revenue, % |
|
|
1.60% |
1.22% |
0.94% |
0.49% |
0.42% |
|
0.42% |
|
| Humana shareholders |
